You are not logged in.
Please login to continue selecting trials.
Generic NameApalutamideProduct NameERLEADA®Therapeutic AreaCancers and Other NeoplasmsEnrollment1207% FemaleN/A% White66.3%
Product ClassNonsteroidal antiandrogenSponsor Protocol NumberARN-509-003Data PartnerJohnson & JohnsonCondition StudiedNeoplasms, ProstaticMean/Median Age (Years)73.9
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- The association between antibiotics exposure and outcomes in men with prostate cancer
- Improving Outcome in Advanced Prostate Cancer: a Pooled Analysis of Randomized Controlled Trials
- Impact of Prior Local Therapy on Outcome in Men with non-metastatic Castrate Resistant Prostate Cancer
- External Validation of a Prognostic Model of Metastasis-Free Survival In Men with Nonmetastatic Castration-Resistant Prostate Cancer